Adenocarcinoma with an EGFR gene mutation (exon 19 deletion L747-E749; A750P) was detected in a transbronchial biopsy specimen; the patient was diagnosed with stage IV (cT2N2M1b) non-small cell lung cancer (NSCLC). This evidence concerns the gene EGFR and adenocarcinoma.